|
ERP44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.99059999945229E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.141710E-03 |
| Normal-vs-Stage2 |
2.126800E-01 |
| Normal-vs-Stage3 |
1.15499999564506E-08 |
| Normal-vs-Stage4 |
3.631100E-04 |
| Stage1-vs-Stage2 |
5.990200E-01 |
| Stage1-vs-Stage3 |
8.767000E-04 |
| Stage1-vs-Stage4 |
3.464400E-02 |
| Stage2-vs-Stage3 |
8.759300E-03 |
| Stage2-vs-Stage4 |
6.285900E-02 |
| Stage3-vs-Stage4 |
7.461200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38029999652289E-08 |
| Normal-vs-AfricanAmerican |
8.753700E-02 |
| Normal-vs-Asian |
1.415670E-03 |
| Caucasian-vs-AfricanAmerican |
6.739600E-01 |
| Caucasian-vs-Asian |
4.007800E-01 |
| AfricanAmerican-vs-Asian |
9.586800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.619200E-04 |
| Normal-vs-Female |
1.37099999997226E-06 |
| Male-vs-Female |
6.274600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.676960E-03 |
| Normal-vs-Age(41-60Yrs) |
3.93560000000459E-05 |
| Normal-vs-Age(61-80Yrs) |
4.06299999977655E-07 |
| Normal-vs-Age(81-100Yrs) |
1.183440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.983800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.137800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.072600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.932760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.101400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.964400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.72559974590081E-10 |
| Classical-VS-Follicular |
7.91770000000414E-05 |
| Classical-VS-Other |
9.749800E-01 |
| Classical-VS-Normal |
3.72009999471956E-08 |
| Tall-VS-Follicular |
1.77724501781995E-12 |
| Tall-VS-Other |
4.940000E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.169000E-01 |
| Follicular-VS-Normal |
3.947600E-01 |
| Other-VS-Normal |
1.756550E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.742200E-03 |
| Normal-vs-N1 |
2.005000E-04 |
| N0-vs-N1 |
5.892400E-02 |
|
|
